Charlson M E, Ales K L, Simon R, MacKenzie C R
Department of Medicine, Cornell University Medical College, New York, NY.
Arch Intern Med. 1987 Dec;147(12):2155-61.
When prognostic indexes have been tested in a second population, they have often performed less well. Since this is believed to be inevitable, methodologic differences that may explain the discrepancies have been overlooked. Data from a prospective study of 232 patients undergoing noncardiac surgery were used to examine the effect of methodologic differences in assembly of population, postoperative surveillance, and the criteria for cardiac complications on the performance of Goldman's cardiac risk index. Our prospective population was used to simulate the methods used in Goldman's study and in three other studies using the risk index to demonstrate the potential impact of differences in population, surveillance, and outcome criteria for cardiac complications. If Goldman's detection and outcome criteria were employed and only the eligibility criteria used for assembly of the populations differed, the overall complication rates would be between 5.2% and 6.9%; and the complication rates for the different Goldman classes were similar. When both different detection strategies and different outcome criteria were used, however, important discrepancies in cardiac complication rates emerged. For example, complication rates in class 2 varied from 2% to 23%. In conclusion, important discrepancies in performance of prognostic indexes may arise from differences in surveillance strategies and definitions of outcome. With sufficient attention to methodologic consistency, the performance of predictive indexes may not inevitably deteriorate in subsequent studies.
当预后指标在另一人群中进行测试时,其表现往往较差。由于人们认为这是不可避免的,所以那些可能解释差异的方法学差异就被忽视了。一项对232例接受非心脏手术患者的前瞻性研究数据,被用于检验在人群构成、术后监测以及心脏并发症标准方面的方法学差异对戈德曼心脏风险指数表现的影响。我们的前瞻性人群被用于模拟戈德曼研究以及其他三项使用该风险指数的研究中所采用的方法,以证明在人群、监测以及心脏并发症结局标准方面的差异可能产生的影响。如果采用戈德曼的检测和结局标准,只是用于人群构成的入选标准不同,那么总体并发症发生率将在5.2%至6.9%之间;不同戈德曼分级的并发症发生率相似。然而,当同时采用不同的检测策略和不同的结局标准时,心脏并发症发生率就出现了显著差异。例如,2级的并发症发生率在2%至23%之间。总之,预后指标表现的显著差异可能源于监测策略和结局定义的不同。如果对方法学的一致性给予足够重视,预测指标在后续研究中的表现不一定会不可避免地变差。